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Abstract 
 
Changes in antioxidant capacity in the body as a result of oxidative stress play an important role in the development of 
diabetic complications. The aim of this study was to evaluate the effect of aqueous extract of Artemisia afra Jacq. ex Willd. on 
antioxidant defense systems in the liver and kidney of streptozotocin–induced diabetic rats. Administration of the extract to 
diabetic rats for 21 days significantly reduced blood glucose levels and increased body weight. The diabetic animals exhibited 
decreased levels of glutathione reductase (GR), glutathione peroxidase (GPx), superoxide dismutase (SOD) and reduced 
glutathione (GSH) in the liver and kidney, which were restored to near normal levels following treatment with the herb. The 
increased levels of lipid peroxidation observed in the tissues of diabetic rats were also reverted back to near normalcy after 
administering the extract. These findings revealed the protective role of A. afra on tissues by reducing oxidative stress which 
could be attributed to its flavonoids content. The efficacy of the plant compared favourably well with glibenclamide, a standard 
hypoglycemic drug. 
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Introduction 
 
Diabetes is a metabolic disorder characterized by chronic hyperglycaemia leading to various dysfunctions in the body. 
Free radical generation is currently suggested to play an important role in the causation and complications of the disease 
(Senthilkumar and Subramanian, 2007). These radicals are continually produced in the body as a result of normal metabolic 
processes and interaction with environmental stimuli. In healthy individuals, the generation of free radical appears to be 
approximately in balance with the antioxidant defense system comprising both enzymatic and non-enzymatic antioxidants. In 
diabetes however, there are alterations in the endogenous free radical scavenging mechanisms which may lead to the production 
of reactive oxygen species, resulting in oxidative damage and tissue injury (Oberley, 1988). Implication of oxidative stress in the 
pathogenesis of diabetes is suggested not only by oxygen-free radicals but also due to non-enzymatic protein glycosylation and 
auto-oxidation of glucose (Mullarkey et al., 1990); alterations in antioxidant enzymes (Strain, 1991) as well as formation of lipid 
peroxides (Baynes, 1991). Enhanced oxidative stress and changes in antioxidant capacity, observed in both clinical and 
experimental diabetes, are thought to be the etiology of diabetic complications (Baynes, 1991). 
The management of diabetes is considered a global problem and there is no successful and definite therapy yet. A few 
chemotherapeutic drugs have been in use to manage the disease since the accidental discovery of the hypoglycemic action of 
sulfonamides (Robinson and Johnston, 1997). The thrust of such management measures is to achieve an effective blood glucose 
control or utilization, with a view to delaying or averting the onset of complications. The application of these measures is however 
limited due to their high cost and associated side effects (Upadhyay et al., 1996; Reynolds, 1997). Recently, attention is being 
focused on the identification of natural antioxidants from plants to replace synthetic ones. Findings from scientific reports have 
shown that plants contain various substances that possess antioxidant activity (Chanwitheesuk et al., 2005). 
Artemisia afra Jacq. ex Willd. (Asteraceae) is locally known as Unhlonyane in Xhosa and African wormwood in 
English. It is one of the widely used medicinal plants in Southern Africa against many ailments. The plant has been employed to 
treat cough, cold, headache, chills, dyspepsia, loss of appetite, gastric derangement, colic, gout, asthma, malaria, diabetes, bladder 
and kidney disorders, influenza, convulsion, fever, heart inflammation, rheumatism and as a purgative (Watt and Breyer-
Brandwijk, 1962; Thring and Weitz, 2006). Phytochemical analyses of A. afra have revealed the presence of tannins, saponins, 
triterpenes, α- and β-amyrin, friedelin as well as the alkanes ceryl cerotinate and n-nonacosane (Silbernagel et al., 1990). The 
major components of its essential oil are α- and β-thujone, 1, 8-cineole and α- pinene (Graven et al., 1992; Viljoen et al., 2006). 
The present study was undertaken to evaluate the antioxidant activity of aqueous leaf extract of Artemisia afra on the 
liver and kidney of streptozotocin-induced diabetic rats and the efficacy was compared with glibenclamide, a standard 
hypoglycemic drug. 
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Materials and methods 
Chemicals 
 
Streptozotocin was procured from Sigma Chemical Co., St. Louis, MO, USA while the assay kits used for biochemical 
analyses were products of Randox Laboratories Limited, Ardmore, Co Antrim, United Kingdom. All other chemicals and reagents 
used were of analytical grade.  
 
Plant material and preparation of extract 
 
Fresh and mature leaves of A. afra were collected around the University of Fort Hare, Alice (Eastern Cape Province, 
South Africa). The plant was authenticated by Prof DS Grierson of Botany Department and a voucher specimen was prepared and 
deposited in the University herbarium. An aqueous extract of the plant was prepared as previously described by Sunmonu and 
Afolayan (2010). The dried plant material recovered was reconstituted in distilled water to give the required doses of 50 and 100 
mg/kg body weight used in the experiment. 
 
Animals 
 
Male albino rats of Wistar strain with a mean weight of 154 ± 4.20 g were used for the experiment. The animals were 
obtained and reared as described by Sunmonu and Afolayan (2011), after seeking approval from the Ethical Committee on the 
Use and Care of Animals of the University of Fort Hare, South Africa. 
 
Induction of diabetes 
 
Diabetes was induced in the rats according to the procedure described by Sunmonu and Afolayan (2010). The animals 
were allowed to drink 5% glucose solution overnight to overcome streptozotocin-induced hypoglycemia. Control rats were 
injected with citrate buffer alone. After 48 h, fasting blood glucose levels were estimated and levels above 250 mg/dl in 
streptozotocin–treated rats confirmed diabetes in the animals. 
 
Animal grouping and extract administration 
 
Thirty male rats were randomized into five groups of six animals and were orally administered appropriately for 21 
days. Group 1 (normal control) and Group 2 (diabetic control) received distilled water. Groups 3 and 4 are diabetic rats treated 
with 50 and 100 mg/kg body weight/day of A. afra extract respectively while Group 5 comprised diabetic rats administered with 
glibenclamide (600 µg/kg body weight/day). The body weights of the animals were determined at the beginning and end of the 
experimental period. 
 
Collection of blood and preparation of tissue homogenate 
 
Twenty four hours after the last dose, blood sample was collected from the tail vein of the animals for estimation of 
glucose level after which the rats were humanely sacrificed by ether anaesthetization. After dissecting the animals, the liver and 
kidney were excised carefully and rinsed immediately in ice cold physiological saline. Known weights of the tissues were 
homogenized in Tris-HCl buffer (pH 7.4) and the resulting homogenates were used for analyses. 
 
Biochemical assays 
 
Tissue protein was estimated according to the method of Lowry et al. (1951) using bovine serum albumin as standard. 
Superoxide dismutase (SOD) activity was determined by the method of Marklund and Marklund (1974). Glutathione reductase 
(GR) activity in the tissues was measured according to the method of Goldberg and Spooner (1983) while glutathione peroxidase 
(GPx) was assayed using the method of Paglia and Valentine (1967). Lipid peroxidation (LPO) was determined by the formation 
of malondialdehyde (MDA)–thiobarbituric acid reactive substances (TBARS) adduct according to the method of Ledwozyw et al. 
(1986). The released malondialdehyde served as the index of lipid peroxidation. Reduced glutathione was estimated by the 
method of Ellman (1959). 
 
Statistical analysis 
 
Data were expressed as mean ± SD for six animals in each group and were subjected to one way analysis of variance 
(ANOVA) followed by Duncan multiple range test to determine significant differences in all the parameters. p values of less than 
0.05 were considered statistically significant.  
 
 
 
Afolayan and Sunmonu Afr J Tradit Complement Altern Med. (2013) 10(1):15-20 
http://dx.doi.org/10.4314/ajtcam.v10i1.3 
17
Results 
Effect of A. afra on hyperglycemia and body weight 
 
Table 1 summarizes blood glucose levels and body weight in the control and experimental groups of animals. The 
diabetic rats showed significant increase in serum glucose levels and significant decrease in body weight compared to the normal 
control. Administration of aqueous extract of A. afra restored glucose levels and body weight to near normal range. 
 
Table 1: Effect of A. afra on blood glucose levels and body weight in diabetic rats (n = 6, X ± SD) 
__________________________________________________________________________________________ 
Body weight (g) 
__________________________________________________________________________________________ 
Treatments    Glucose (mg/dl) Initial   Final 
___________________________________________________________________________________________ 
Normal control   73.13 ± 3.89a  154.18 ± 4.96a  185.48 ± 4.42a 
Diabetic control   318.98 ± 6.31b  154.40 ± 4.11a  157.57 ± 4.42b 
Diabetic + 50 mg/kg A. afra  77.64 ± 2.13a  154.85 ± 4.19a  175.40 ± 4.14c 
Diabetic + 100 mg/kg A. afra  75.53 ± 3.31a  154.73 ± 4.10a  173.33 ± 4.41c 
Diabetic + glibenclamide  75.30 ± 2.75a  154.37 ± 3.99a  174.97 ± 3.89c 
___________________________________________________________________________________________ 
Values along the same column with different superscripts are significantly different (p<0.05). 
 
 
Effect of A. afra on lipid peroxidation and GSH content 
 
As reported in Table 2, there was a significant elevation in MDA and a significant decrease in GSH levels in the liver 
and kidney of diabetic rats. Treatment with the herb resulted in a marked improvement in these indices at the end of the 
experiment as they were reverted back to normalcy after 21 days. 
 
Table 2: Effect of A. afra on malondialdehyde and reduced glutathione levels in the liver and kidney of diabetic rats (n = 6, X ± 
SD) 
________________________________________________________________________________________________________ 
Malondialdehyde (MDA)     Reduced glutathione (GSH)  
(nmol/mg protein)      (nmol/g tissue) 
Treatments _______________________________________________________________________________________ 
                                              Liver    Kidney 
   Liver  Kidney 
________________________________________________________________________________________________________
____ 
Normal control   0.84 ± 0.06a   1.26 ± 0.22a   40.39 ± 
3.61a  28.85 ± 1.85a  
Diabetic control   1.36 ± 0.16b   2.05 ± 0.27b   21.44 ± 
2.36b  16.08 ± 1.24b  
Diabetic + 50 mg/kg A. afra  0.85 ± 0.07a   1.28 ± 0.10a   36.58 ± 
2.33a  26.27 ± 1.76a 
Diabetic + 100 mg/kg A. afra  0.84 ± 0.08a   1.26 ± 0.19a   39.76 ± 
2.36a  27.10 ± 1.50a  
Diabetic + glibenclamide  0.88 ± 0.06a   1.30 ± 0.19a   35.70 ± 
2.31a  25.40 ± 1.60a  
________________________________________________________________________________________________________ 
Values along the same column with different superscripts are significantly different (p<0.05). 
 
 
 
Effect of A. afra on the activities of antioxidant enzymes 
 
Tables 3 and 4 show the activities of enzymic antioxidants (GPx, GR and SOD) in the liver and kidney respectively. 
Significantly decreased activities of these enzymes were observed in the tissues of diabetic rats. However, these activities were 
significantly improved following administration of the extract for 21 days. Generally, the effect of the extract compared 
favourably well with glibenclamide, a standard hypoglycemic drug. 
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Table 3: Effect of A. afra on the activities of antioxidant enzymes in the liver of diabetic rats (n = 6, X ± SD) 
________________________________________________________________________________________________________ 
Glutathione reductase (GR)  Glutathione peroxidase (GPx) Superoxide dismutase (SOD)  
Treatments   (U/I/mg protein)   (U/I/mg protein)(Units/mg protein)   
________________________________________________________________________________________________________ 
Normal control   49.68 ± 3.06a   60.50 ± 3.61a   
 8.33 ± 0.62a    
Diabetic control   20.39 ± 2.16b   26.16 ± 1.81b    
 4.34 ± 0.57b    
Diabetic + 50 mg/kg A. afra  44.88 ± 3.07a   55.42 ± 3.36a    
 7.38 ± 0.69a   
Diabetic + 100 mg/kg A. afra  47.37 ± 2.88a   57.46 ± 3.50a    
 7.56 ± 0.59a    
Diabetic + glibenclamide  43.98 ± 3.16a   54.83 ± 3.60a    
 7.33 ± 0.49a   
________________________________________________________________________________________________________ 
Values along the same column with different superscripts are significantly different (p<0.05). 
 
 
Table 4: Effect of A. afra on the activities of antioxidant enzymes in the kidney of diabetic rats (n = 6, X ± SD) 
________________________________________________________________________________________________________ 
Glutathione reductase (GR)  Glutathione peroxidase (GPx) Superoxide dismutase (SOD)  
Treatments   (U/I/mg protein)   (U/I/mg protein)(Units/mg protein)   
________________________________________________________________________________________________________ 
Normal control   33.57 ± 2.66a   43.60 ± 2.16a   
 13.35 ± 0.81a    
Diabetic control   11.18 ± 2.16b   15.06 ± 1.31b    
 8.30 ± 0.75b    
Diabetic + 50 mg/kg A. afra  29.78 ± 3.04a   38.92 ± 2.63a    
 12.29 ± 0.62a   
Diabetic + 100 mg/kg A. afra  32.47 ± 2.58a   40.96 ± 2.15a    
 12.74 ± 0.57a    
Diabetic + glibenclamide  28.98 ± 3.16a   38.33 ± 2.87a    
 11.93 ± 0.94a   
________________________________________________________________________________________________________ 
Values along the same column with different superscripts are significantly different (p<0.05). 
 
 
 
Discussion 
 
Many of the complications of diabetes have been linked to oxidative stress and antioxidants have been considered as 
treatments (Reaven et al., 1995; Cunningham, 1998). Hence, it could be suggested that antioxidant action may be an important 
property of plant medicines associated with diabetes. The present study has clearly demonstrated that aqueous extract of Artemisia 
afra has antioxidant activity; and the efficacy is comparable to glibenclamide, a standard hypoglycemic drug. Increase in blood 
glucose level is an important characteristic feature of diabetic state. The extract from A. afra produced significant hypoglycemic 
effect in diabetic rats and by day 21, the glucose levels tended towards normalcy as found in the control. Microchemical analyses 
of the plant have indicated the presence of saponins (Silbernagel et al., 1990) which had been reported to possess hypoglycemic 
activity in diabetic rabbits (Abdel-Hassan et al., 2000). Therefore, the hypoglycemic activity of A. afra observed in this study 
could be attributed to the presence of saponin. 
The reduction in body weight observed in diabetic rats could be attributed to excessive breakdown of tissue proteins 
(Chatterjea and Shinde, 2002). The improvement in body weight in the A. afra treated rats could be due to increase in metabolic 
activity. This clearly indicates that the plant extract increased glucose metabolism and thus enhanced body weight in diabetic rats. 
Similar observation was reported by Ravi et al. (2004a). According to these authors, Eugenia jambolana seed kernels enhanced 
body weight of diabetic rats. 
Most tissue damages are mediated by free radicals which attack membranes through peroxidation of unsaturated fatty 
acids (Stringer et al., 1989). Diabetes induction with streptozotocin in rats results in an increase in lipid peroxidation, which is an 
evidence of intensified free radical production (Maritim et al., 2003). In this study, the levels of malondialdehyde (MDA) were 
increased in the liver and kidney of diabetic rats which is an indication of increased free radical generation leading to oxidative 
stress in the tissues. Administration of the extract significantly reduced MDA level, which suggests that the extract might possess 
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antioxidant activity. This is an indication that the herb has a protective effect by ameliorating tissue oxidative stress. Similar 
observation was reported by Ravi et al. (2004b) using E. jambolana seed kernel in STZ treated rats. The evidence presented in 
this study suggests that the antioxidative role of A. afra could be attributed to its flavonoids content which act as strong free 
radical scavengers. 
Glutathione is an important antioxidant which plays the role of an intracellular radical scavenger and is a substrate for 
many xenobiotic elimination reactions (Gregus et al., 1996). Decreased levels of reduced glutathione (GSH) observed in the liver 
and kidney of diabetic rats may be a result of increased oxidative stress. GSH has the ability to manage oxidative stress with 
adaptional changes in enzymes regulating GSH metabolism (Arulselvan and Subramanian, 2007). The treatment of the rats with 
A. afra extract significantly increased the GSH levels in their tissues and consequently improved the antioxidant status. This 
increase may, in turn, activate GSH dependent enzymes such as glutathione peroxidase and glutathione reductase. 
Increased concentrations of ROS have been implicated in many of diabetic complications (Halliwell and Gutteridge, 
1989). The present findings indicate significantly reduced tissue antioxidant enzymic activities in diabetic rats and its attenuation 
by A. afra treatment. GPx is involved in the reduction of hydrogen peroxide to water by using glutathione as a hydrogen donor 
(Sies, 1993). Reduced activity of this enzyme in the liver and kidney of diabetic rats has been observed in the current study. Our 
result is consistent with Ravi et al. (2004b) who reported a reduction in the activity of tissue antioxidant enzymes in diabetic rats. 
The reduced activity of GPx may result in accumulation of toxic products due to oxidative damage; and its recovery following 
treatment with A. afra extract indicates the protective effect of the herb on antioxidants. 
The decreased activities of SOD and GR in both liver and kidney during diabetes as observed in this study may be due 
to increased production of reactive oxygen radicals which are capable of reducing the activities of these enzymes (Wohaieb and 
Godin, 1987). SOD is an important defense enzyme which catalyses the dismutation of superoxide radicals while GR is required 
for the conversion of oxidized (GSSG) to reduced glutathione (GSH). Oral administration of A. afra increased the activities of 
these enzymes which may help to scavenge the free radicals generated during diabetes. This is indicative of the protective role of 
the herb on antioxidant enzymes in the tissues. Generally, the effect of the treatment with A. afra compared favourably with the 
effect of glibenclamide, a known standard drug for diabetes. 
 
Conclusion 
 
Aside its hypoglycemic action, findings from the present study clearly revealed antioxidant property of aqueous extract 
of A. afra which could protect tissues from oxidative damage. This is an indication that the extract could be a very useful 
therapeutic agent for treating radical–related pathological damages. 
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